Search

Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. FVC is considered to be a basic indicator of the outcome of COVID-19 because shortness of breath is one of the major persistent predominating symptoms in post-COVID-19 patients. To date, we have already registered 171 confirmed myasthenia gravis (MG) patients with COVID-19 infection, so at present this patient cohort is practically twice the original set. [Extracted from the article]